Tech Comm Available Technologies :: The Research Institute at Nationwide Children's Hospital, Columbus, Ohio

Details

Project TitleMonoclonal and Polyclonal Antibodies against Anoctamin 5
Track Code2012-012
Websitehttp://www.nationwidechildrens.org/technology-commercialization
Short Description

Polyclonal antibodies against human Anoctamin 5 (ANO5) for use in diagnosis and research.

Abstract

Researchers at Nationwide Children’s Hospital have developed a polyclonal antibody directed against human Anoctamin 5 (ANO5). Defects in ANO5 are the causative agent of Limb Girdle Muscular Dystrophy Type 2L (LGMD 2L), an autosomal recessive degenerative myopathy. This antibody can be used as a diagnostic and for research applications.

 
Tagsresearch tool, Limb Girdle Muscular Dystrophy, antibody
 
Posted DateJan 24, 2014 1:05 PM

Researcher

Name
Louise Rodino-Klapac
William Grose
Danielle Griffin

Manager

Name
Margaret Barkett

Inquiry

Margaret Barkett, Ph.D.

The Research Institute at Nationwide Children's Hospital

Office of Technology Commercialization

700 Children's Drive

Columbus OH 43205

T: 614 355-2957    F: 614 722-2716

Margaret.Barkett@nationwidechildrens.org

Intellectual Property

Patent Number Issue Date Type Country of Filing
None None Other Patent None
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000